Novo Nordisk CEO takes aim at U.S. health system in Ozempic testimony
- Posted on September 24, 2024
- By Fortune
- 5 Views
Novo Nordisk CEO takes aim at U.S. health system in Ozempic testimony
Novo Nordisk's CEO said the complexities of the U.S. healtchare system prevented access to $1,349 Wegovy.
